Abko Calls Extraordinary General Meeting to Add AI Medical, Biosensor Business Purposes via Article Amendment

Extraordinary General Meeting: 2026.05.29, Seoul Gangseo HQ.
Agenda: Amend Article 2 (Purpose) – Add 7 new business purposes including AI-based medical solutions, medical robotics, biosensors, AI diagnostic algorithms, medical device manufacturing/sales.
Objective: Diversify into healthcare beyond existing gaming gear, small appliances, public projects.
Outside director Kim Jong-dae, 100% board attendance, compensation 1,000 KRW per person (total 3,000 KRW).
Electronic voting (K-VOTE) available from 2026.05.19 to 05.28.
No financial statement approval, dividends, or treasury stock matters.